Westerly, RI, United States of America

Daniel Copley Schmitt

USPTO Granted Patents = 3 

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Westerli, RI (US) (2021)
  • Westerly, RI (US) (2023)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
3 patents (USPTO):

Title: The Innovations of Daniel Copley Schmitt: A Pioneer in CCR6 Inhibition

Introduction: Daniel Copley Schmitt, based in Westerly, Rhode Island, has made significant contributions to the field of pharmaceutical innovation. With two patents to his name, Schmitt's work focuses on the development of compounds that have promising applications in treating various diseases through the inhibition of specific receptors.

Latest Patents: Schmitt's latest patents revolve around N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides, which serve as CCR6 inhibitors. These innovative compounds, detailed in his patents, are designed to inhibit the CC chemokine receptor 6 (CCR6), offering potential therapeutic options for diseases, conditions, or disorders that can be ameliorated through CCR6 inhibition. The patents highlight not just the compounds themselves but also their pharmaceutical compositions and applications in medicine.

Career Highlights: Schmitt works at Pfizer Corporation, a leading player in the pharmaceutical industry. His research and development efforts contribute to the company’s mission of advancing health care solutions. His two patents reflect his deep commitment to medical innovation and his expertise in drug development.

Collaborations: Throughout his career, Schmitt has collaborated with esteemed colleagues such as Brian Stephen Gerstenberger and Andrew Christopher Flick. These partnerships enhance the breadth of research and innovation, allowing for a multidisciplinary approach to pharmaceutical development.

Conclusion: Daniel Copley Schmitt exemplifies the spirit of innovation within the pharmaceutical field. His work on CCR6 inhibitors marks an important advancement in treating various diseases, underscoring the vital role that inventors play in the medical landscape. As he continues his work at Pfizer Corporation, it will be exciting to see how his innovations will impact healthcare in the years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…